ATL-105

N/A

Report date: 2024/04/08 16:37:35

Base Information

Drug NameATL-105
Drug Alias NameATL-105alpha-1 antitrypsin(AATec Medical GmbH)
ClassificationBiologics > Protein drugs
Mechanisms of ActionAlpha-1-antiproteinase replacements
TargetsAlpha-1-antiproteinase
Therapy Area/IndicationsRespiratory Distress Syndrome, AdultPulmonary Disease, Chronic ObstructiveBronchiolitis Obliterans +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAATec Medical GmbH
China Registration ClassN/A

Develop Information

Active CompaniesAATec Medical GmbHFederal Agency For Disruptive Innovation, Germany
Inactive CompaniesN/A
Active IndicationsRespiratory Distress Syndrome, AdultPulmonary Disease, Chronic ObstructiveBronchiolitis Obliterans +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A